Pfizer has the highest sales rep visitation rate in China followed by AstraZeneca and Bayer:PatientsMap 2018 CN asks doctors about sales rep visitations of 69 pharmaceutical companies in the past month. Below table shows the top 15 pharmaceutical companies with the highest sales rep visitation rates. Top 7 companies are major global pharmaceutical companies, and Chinese local companies ranked 8th, 10th, 12th and 15th. No Japanese companies ranked within the top 15th, with the highest being Eisai at 21st (8.1%).
PatientsMap2018 CN- Top 15 Sales Rep visit ranking (n=10,285）
|Overall rank||Company Name||N=||%|
|8||CHIA TAI TIANQING (CTTQ) Pharmaceutical||1,675||16.3%|
|10||Yangtze River Pharmaceutical (Group)||1,618||15.7%|
|15||Jiangsu Hengrui Medicine Distribution||1,176||11.4%|
Focusing only on Japanese companies, "Eisai" ranked 21st overall and its sales rep visit visitation rate was 8%. As below, Takeda ranked 27th, Daiichi Sankyo 30th, Otsuka 32nd in order
PatientsMap 2018CN Sales Rep visit – Japanese company (n=10,285）
|Overall rank||Company Name||N=||％|
|37||Sumitomo Dainippon Pharma||340||3.3%|
SSRI and M3 started selling PatientsMap 2018CN since June 4, 2018.
The Japanese version of PatientsMap is a database that investigates the number of patients with about 400 diseases through cooperation of over 20,000 doctors every year.
PatientsMap has also released US and UK versions so far, the Chinese version is the 4th country as the PatientsMap series
“PatientsMap 2018CN” – Outline-
The respondents of this study was randomly selected per specialty/department from members of medlive.cn, administrated by Chinese affliate of m3.com and is a portal site for healthcare professionals with 2,130,000 online members,.
Studied medical conditions: 357 conditions
Sample source: M3 Global Research online physician panel
Sample department: All departments in hospitals and clinics
Methodology: Online survey
Sample size: Total of 10,285 physicians
Fieldwork schedule: 3rd January 2018~6th March 2018
Contents of the survey: Medical conditions that they treat
Number of patients they see per medical condition
Number of patients in which they administer medicine to
Medical conditions in which they wish for new products
Sales rep visitation status
This service is provided jointly by Social Survey Research Co., Ltd., M3, Inc. and M3 Global Research.
■Contact Information Social Survey Research Information Co., Ltd
Contact: Chiharu Sakai
■ Social Survey Research Information Co., Ltd
Established April 1982
Capital 27 million yen
Executive President & CEO Takashi Makita
Staff 110 staff members
Address NMF Shinjuku EAST Bldg.
10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067
Osaka Office Tetsutani Bldg. 502
2-2-2 Tokui-cho, Chuo-ku, Osaka540-0025
Affiliate companies PD Research Co., Ltd.
SSRI-CHINA Co., Ltd.
- M3, Inc.
Established September 2000
Capital 15 billion and 31 million yen
Director Representative Director Itaru Tanimura
Subsidiaries staff 3,556 staff members (as of end of March 2016)
Address Akasaka Intercity 10th floor
Minato-ku, Tokyo 107-0052
Established: April 2013
Capital: 2 million CNY
General manager: Tian Liping
Number of staffs: 210
Address: Beijing Red Manor International Bonded Innovation Park E-1,
Baijialou 1, Chaoyang North Road, Chaoyang District,